Insider Trading Alert - EBay And 4 Others Traded By Insiders

Yesterday, June 28, 2013, 151 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $599.84 to $135,048,585.84.

Highlighted Stocks Traded by Insiders:

eBay (EBAY) - FREE Research Report

OMIDYAR PIERRE M who is Director at EBAY INC bought 105,000 shares on April 29, 2013. Following this transaction, the Director owned 121.8 million shares meaning that the stake was boosted by 0.09% with the 105,000 share acquisition.

The shares most recently traded at $52.12, down $0.02, or 0.03% since the insider transaction. Historical insider transactions for eBay go as follows:

  • 4-Week # shares sold: 2,000
  • 12-Week # shares sold: 41,329
  • 24-Week # shares sold: 54,566

The average volume for eBay has been 10.3 million shares per day over the past 30 days. eBay has a market cap of $66.6 billion and is part of the services sector and retail industry. Shares are up 2.24% year to date as of the close of trading on Thursday.

eBay Inc. provides online platforms, tools, and services to help individuals and merchants in online and mobile commerce and payments in the United States and internationally. The company has a P/E ratio of 25.0. Currently there are 23 analysts that rate eBay a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EBAY - FREE

TheStreet Quant Ratings rates eBay as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full eBay Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

VCA Antech (WOOF) - FREE Research Report

ANTIN ARTHUR J who is COO & Senior Vice President at VCA ANTECH INC sold 32,613 shares at $25.08 per share for a total value of $817,934.04 on June 24, 2013. Following this transaction, the COO & Senior Vice President owned 534,827 shares meaning that the stake was reduced by 5.75% with the 32,613 share sell-off.

ANTIN ROBERT L who is CEO, President & Chairman at VCA ANTECH INC sold 65,225 shares at $25.08 per share for a total value of $1,635,843.00 on June 24, 2013. Following this transaction, the CEO, President & Chairman owned 2.6 million shares meaning that the stake was reduced by 2.47% with the 65,225 share sell-off.

Drake Josh who is President, Antech Diagnostics at VCA ANTECH INC sold 4,698 shares at $25.08 per share for a total value of $117,825.84 on June 24, 2013. Following this transaction, the President, Antech Diagnostics owned 55,242 shares meaning that the stake was reduced by 7.84% with the 4,698 share sell-off.

FULLER TOMAS W who is CFO, VP & Secretary at VCA ANTECH INC sold 11,274 shares at $25.08 per share for a total value of $282,751.92 on June 24, 2013. Following this transaction, the CFO, VP & Secretary owned 246,470 shares meaning that the stake was reduced by 4.37% with the 11,274 share sell-off.

TAUBER NEIL who is Senior VP at VCA ANTECH INC sold 10,335 shares at $25.08 per share for a total value of $259,201.80 on June 24, 2013. Following this transaction, the Senior VP owned 158,288 shares meaning that the stake was reduced by 6.13% with the 10,335 share sell-off.

The shares most recently traded at $25.85, up $0.10, or 0.39% since the insider transactions. Historical insider transactions for VCA Antech go as follows:

  • 4-Week # shares sold: 6,673
  • 12-Week # shares sold: 6,673
  • 24-Week # shares sold: 8,237

The average volume for VCA Antech has been 757,600 shares per day over the past 30 days. VCA Antech has a market cap of $2.2 billion and is part of the services sector and diversified services industry. Shares are up 22.33% year to date as of the close of trading on Thursday.

VCA Antech, Inc. operates as an animal healthcare company in the United States and Canada. It operates through two segments, Animal Hospital and Laboratory. The company has a P/E ratio of 58.6. Currently there are 4 analysts that rate VCA Antech a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WOOF - FREE

TheStreet Quant Ratings rates VCA Antech as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full VCA Antech Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Molina Healthcare (MOH) - FREE Research Report

MOLINA JOHN C who is CFO at MOLINA HLTHCR bought 2.6 million shares at $15.46 per share for a total value of $1,000,014.04 on June 24, 2013. Following this transaction, the CFO owned 4.2 million shares meaning that the stake was boosted by 157.67% with the 2.6 million share acquisition.

The shares most recently traded at $37.35, down $0.04, or 0.1% since the insider transaction. Historical insider transactions for Molina Healthcare go as follows:

  • 4-Week # shares sold: 27,723
  • 12-Week # shares bought: 7,000
  • 12-Week # shares sold: 51,162
  • 24-Week # shares bought: 7,000
  • 24-Week # shares sold: 111,162

The average volume for Molina Healthcare has been 652,800 shares per day over the past 30 days. Molina Healthcare has a market cap of $1.7 billion and is part of the health care sector and health services industry. Shares are up 38.17% year to date as of the close of trading on Thursday.

Molina Healthcare, Inc. provides Medicaid-related solutions to meet the health care needs of low-income families and individuals, as well as to assist state agencies in their administration of the Medicaid program. The company has a P/E ratio of 81.3. Currently there are 4 analysts that rate Molina Healthcare a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MOH - FREE

TheStreet Quant Ratings rates Molina Healthcare as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in net income, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Molina Healthcare Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Acacia Research Coroporation (ACTG) - FREE Research Report

HAYNES CLAYTON J who is Sr.V.P, CFO at ACACIA RESEARCH bought 4,221 shares at $17.32 per share for a total value of $41,794.27 on June 25, 2013. Following this transaction, the Sr.V.P, CFO owned 227,736 shares meaning that the stake was boosted by 1.87% with the 4,221 share acquisition.

The shares most recently traded at $22.17, up $0.17, or 0.77% since the insider transaction. Historical insider transactions for Acacia Research Coroporation go as follows:

  • 4-Week # shares sold: 2,000
  • 12-Week # shares sold: 31,778
  • 24-Week # shares sold: 35,463

The average volume for Acacia Research Coroporation has been 677,800 shares per day over the past 30 days. Acacia Research Coroporation has a market cap of $1.1 billion and is part of the services sector and diversified services industry. Shares are down 13.87% year to date as of the close of trading on Thursday.

Acacia Research Corporation, through its subsidiaries, acquires, develops, licenses, and enforces patented technologies in the United States. The stock currently has a dividend yield of 2.26%. The company has a P/E ratio of 85.0. Currently there are 4 analysts that rate Acacia Research Coroporation a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on ACTG - FREE

TheStreet Quant Ratings rates Acacia Research Coroporation as a hold. Among the primary strengths of the company is its solid financial position based on a variety of debt and liquidity measures that we have evaluated. At the same time, however, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full Acacia Research Coroporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Green Mountain Coffee Roasters (GMCR) - FREE Research Report

MILLER HINDA who is Director at GREEN MTN COFFE sold 10,000 shares at $75.16 per share for a total value of $751,800.15 on June 25, 2013. Following this transaction, the Director owned 166,472 shares meaning that the stake was reduced by 5.67% with the 10,000 share sell-off.

The shares most recently traded at $75.53, up $1.69, or 2.29% since the insider transaction. Historical insider transactions for Green Mountain Coffee Roasters go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 10,000
  • 24-Week # shares sold: 10,000

The average volume for Green Mountain Coffee Roasters has been 3.8 million shares per day over the past 30 days. Green Mountain Coffee Roasters has a market cap of $11.3 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 78.62% year to date as of the close of trading on Thursday.

Green Mountain Coffee Roasters, Inc. engages in the specialty coffee and coffeemaker businesses in the United States and Canada. The company has a P/E ratio of 30.0. Currently there are 10 analysts that rate Green Mountain Coffee Roasters a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GMCR - FREE

TheStreet Quant Ratings rates Green Mountain Coffee Roasters as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Green Mountain Coffee Roasters Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Dow Logs Eighth Straight Drop as Stocks Slump

Dow Logs Eighth Straight Drop as Stocks Slump

This Is What's Hot Thursday - Stocks Slide, Intel's CEO Woes & Major Movers

This Is What's Hot Thursday - Stocks Slide, Intel's CEO Woes & Major Movers

U.S. Banks Pass Fed 'Stress Test' With Room for Dividends, Buybacks

U.S. Banks Pass Fed 'Stress Test' With Room for Dividends, Buybacks

U.S. Drillers at Mercy of Iran, Saudi Production Spat as OPEC Meeting Begins

U.S. Drillers at Mercy of Iran, Saudi Production Spat as OPEC Meeting Begins

Comcast's Brian Roberts vs. Disney's Bob Iger: Which Titan Will Nab Fox?

Comcast's Brian Roberts vs. Disney's Bob Iger: Which Titan Will Nab Fox?